D 2022

NOVEL 1,3,5-TRIAZINYL AMINOBENZENESULFONAMIDES AS POTENT ANTI-VRE AGENTS, AND CARBONIC ANHYDRASES I, II, VII, IX, AND XII INHIBITORS

HAVRÁNKOVÁ, Eva, Josef JAMPÍLEK, Vladimír GARAJ and Claudiu T. SUPURAN

Basic information

Original name

NOVEL 1,3,5-TRIAZINYL AMINOBENZENESULFONAMIDES AS POTENT ANTI-VRE AGENTS, AND CARBONIC ANHYDRASES I, II, VII, IX, AND XII INHIBITORS

Authors

HAVRÁNKOVÁ, Eva (203 Czech Republic, guarantor, belonging to the institution), Josef JAMPÍLEK (203 Czech Republic), Vladimír GARAJ (703 Slovakia) and Claudiu T. SUPURAN (380 Italy)

Edition

Prague, Czech republic, Czech Chemical Society Symposium Series, p. 14-15, 2 pp. 2022

Publisher

Czech Chemical Society

Other information

Language

English

Type of outcome

Stať ve sborníku

Field of Study

30107 Medicinal chemistry

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Publication form

electronic version available online

References:

RIV identification code

RIV/00216224:14160/22:00126647

Organization unit

Faculty of Pharmacy

ISSN

Keywords in English

carbonic anhydrases; vancomycin-resistant enterococci; anti-VRE agents; triazinyl-benzenesulfonamides

Tags

Reviewed
Změněno: 13/9/2022 14:00, RNDr. Eva Havránková, Ph.D.

Abstract

V originále

Carbonic anhydrases (CA, EC 4.2.1.1) are metallo-enzymes present in various organisms. In pathogenic bacteria, CAs play an important role in growth and survival. Inhibition of bacterial CAs leads to growth defects, growth retardation and makes bacterias vulnerable to host defense mechanisms. Bacterial CAs are therefore a very promising target in the search for new antibiotics. A series of 1,3,5-triazinyl aminobenzenesulfonamides substituted by aminoalcohol, aminostilbene, and aminochalcone structural motifs were synthesized as potential bacterial CAs inhibitors. Newly prepared compounds have a great potential as antibacterial agents with high activity and at the same time with high selectivity for bacterial CA in comparison with metabolically important hCA isoenzymes (e.g. hCA I, hCA II) found in the human body.

Links

MUNI/A/1202/2020, interní kód MU
Name: Syntéza nových potenciálních inhibitorů CA
Investor: Masaryk University